
Benzinga · 28 de jul de 2026
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here…
Novo Nordisk A/S
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
No hay suficientes datos históricos para mostrar el gráfico de NVO.
Precio
$ 11.620
Var. %
0%
Precio NVO
US$ 50,96
Teórico (precio / ratio)
NVO ÷ 7
US$ 7,28
Cotización
US$ 7,55
vs teórico
+3,71%
Cotización MEP implícita
$ 1.539,07
Cotización
—
vs teórico
—
Cotización Cable implícita
—
Sí, existe el CEDEAR de NVO (Novo Nordisk A/S) en la Bolsa de Comercio de Buenos Aires (BYMA). Su ticker local es NVO.
El ticker del CEDEAR de Novo Nordisk A/S en Argentina es NVO. La acción subyacente cotiza en NYSE con el símbolo NVO.
El CEDEAR NVO tiene un ratio de 7:1. Eso significa que 7 CEDEARs equivalen a 1 acción de NVO.
El CEDEAR NVO cotiza hoy a $ 11.620 en pesos argentinos, con una variación diaria de 0%.
La acción subyacente NVO (Novo Nordisk A/S) cotiza a US$ 50,96 en su mercado de origen (NYSE).
El precio teórico del CEDEAR NVO se calcula dividiendo el precio de NVO por el ratio (7). Hoy resulta en US$ 7,28.
En BYMA podés operar NVO en pesos, NVOD en dólar MEP y NVOC en dólar cable. Cada modalidad refleja un tipo de cambio distinto.
En esta página encontrás un gráfico con el precio histórico del CEDEAR NVO en pesos argentinos, con datos de data912.

Benzinga · 28 de jul de 2026
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here…

Benzinga · 27 de jul de 2026
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here…

SeekingAlpha · 27 de jul de 2026
Novo Nordisk (NVO) is rated a Modest Buy with a raised price target of $80, driven by oral Wegovyâs rapid market adoption.

SeekingAlpha · 27 de jul de 2026
Novo Nordisk (NVO) outlook: Q2 earnings, Oral Wegovy momentum, global approvals, China filing and CagriSema catalystsâsee why bulls stay optimistic.

SeekingAlpha · 26 de jul de 2026
Novo Nordisk's oral Wegovy is expanding the treated obesity market, not just cannibalizing injectables. Read why NVO stock is a Buy.

SeekingAlpha · 26 de jul de 2026
The series targets generating 12â15% annualized income through disciplined selling of PUT and BUY-WRITE CALL options on large-cap stocks. Check out the strate…

SeekingAlpha · 26 de jul de 2026
Novo Nordisk rated a hold as Ozempic/Rybelsus weakness hits revenue despite strong cash flow and cheap valuation. Click for more on NVO stock.
Benzinga · 24 de jul de 2026
https://www.aboutamazon.com/news/devices/new-alexa-top-features
Noticias vía Finnhub